Cargando…

RNA therapeutics

“RNA therapeutics” refers to a disease treatment or drug that utilizes RNA as a component. In this context, RNA may be the direct target of a small-molecule drug or RNA itself may be the drug, designed to bind to a protein, or to mimic or target another RNA. RNA has gained attention in the drug-deve...

Descripción completa

Detalles Bibliográficos
Autores principales: Hastings, Michelle L., Krainer, Adrian R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cold Spring Harbor Laboratory Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019368/
https://www.ncbi.nlm.nih.gov/pubmed/36928165
http://dx.doi.org/10.1261/rna.079626.123
_version_ 1784908012915261440
author Hastings, Michelle L.
Krainer, Adrian R.
author_facet Hastings, Michelle L.
Krainer, Adrian R.
author_sort Hastings, Michelle L.
collection PubMed
description “RNA therapeutics” refers to a disease treatment or drug that utilizes RNA as a component. In this context, RNA may be the direct target of a small-molecule drug or RNA itself may be the drug, designed to bind to a protein, or to mimic or target another RNA. RNA has gained attention in the drug-development world, as recent clinical successes and breakthrough technologies have revolutionized the drug-like qualities of the molecule or its usefulness as a drug target. In this special issue of RNA, we gathered expert perspectives on the past, present, and future of the field, to serve as a primer and also a challenge to the broad scientific community to incorporate RNA into their experimental design and problem-solving process, and to imagine and realize the potential of RNA as a therapeutic drug or target.
format Online
Article
Text
id pubmed-10019368
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Cold Spring Harbor Laboratory Press
record_format MEDLINE/PubMed
spelling pubmed-100193682023-04-01 RNA therapeutics Hastings, Michelle L. Krainer, Adrian R. RNA Introduction “RNA therapeutics” refers to a disease treatment or drug that utilizes RNA as a component. In this context, RNA may be the direct target of a small-molecule drug or RNA itself may be the drug, designed to bind to a protein, or to mimic or target another RNA. RNA has gained attention in the drug-development world, as recent clinical successes and breakthrough technologies have revolutionized the drug-like qualities of the molecule or its usefulness as a drug target. In this special issue of RNA, we gathered expert perspectives on the past, present, and future of the field, to serve as a primer and also a challenge to the broad scientific community to incorporate RNA into their experimental design and problem-solving process, and to imagine and realize the potential of RNA as a therapeutic drug or target. Cold Spring Harbor Laboratory Press 2023-04 /pmc/articles/PMC10019368/ /pubmed/36928165 http://dx.doi.org/10.1261/rna.079626.123 Text en © 2023 Hastings and Krainer; Published by Cold Spring Harbor Laboratory Press for the RNA Society https://creativecommons.org/licenses/by-nc/4.0/This article, published in RNA, is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) .
spellingShingle Introduction
Hastings, Michelle L.
Krainer, Adrian R.
RNA therapeutics
title RNA therapeutics
title_full RNA therapeutics
title_fullStr RNA therapeutics
title_full_unstemmed RNA therapeutics
title_short RNA therapeutics
title_sort rna therapeutics
topic Introduction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10019368/
https://www.ncbi.nlm.nih.gov/pubmed/36928165
http://dx.doi.org/10.1261/rna.079626.123
work_keys_str_mv AT hastingsmichellel rnatherapeutics
AT kraineradrianr rnatherapeutics